12-89615182-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001366521.1(ATP2B1):​c.2067+1620T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.15 in 152,102 control chromosomes in the GnomAD database, including 2,076 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.15 ( 2076 hom., cov: 32)

Consequence

ATP2B1
NM_001366521.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.191

Publications

148 publications found
Variant links:
Genes affected
ATP2B1 (HGNC:814): (ATPase plasma membrane Ca2+ transporting 1) The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 1. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
ATP2B1 Gene-Disease associations (from GenCC):
  • intellectual developmental disorder, autosomal dominant 66
    Inheritance: AD, AR Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.339 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001366521.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP2B1
NM_001366521.1
MANE Select
c.2067+1620T>C
intron
N/ANP_001353450.1P20020-3
ATP2B1
NM_001366524.1
c.2067+1620T>C
intron
N/ANP_001353453.1P20020-4
ATP2B1
NM_001366525.1
c.2067+1620T>C
intron
N/ANP_001353454.1P20020-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP2B1
ENST00000428670.8
TSL:5 MANE Select
c.2067+1620T>C
intron
N/AENSP00000392043.3P20020-3
ATP2B1
ENST00000960959.1
c.2067+1620T>C
intron
N/AENSP00000631018.1
ATP2B1
ENST00000960960.1
c.2067+1620T>C
intron
N/AENSP00000631019.1

Frequencies

GnomAD3 genomes
AF:
0.150
AC:
22754
AN:
151984
Hom.:
2071
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.102
Gnomad AMI
AF:
0.0647
Gnomad AMR
AF:
0.124
Gnomad ASJ
AF:
0.240
Gnomad EAS
AF:
0.330
Gnomad SAS
AF:
0.353
Gnomad FIN
AF:
0.0766
Gnomad MID
AF:
0.244
Gnomad NFE
AF:
0.163
Gnomad OTH
AF:
0.162
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.150
AC:
22758
AN:
152102
Hom.:
2076
Cov.:
32
AF XY:
0.151
AC XY:
11261
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.102
AC:
4250
AN:
41486
American (AMR)
AF:
0.123
AC:
1886
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.240
AC:
834
AN:
3470
East Asian (EAS)
AF:
0.330
AC:
1707
AN:
5174
South Asian (SAS)
AF:
0.353
AC:
1699
AN:
4812
European-Finnish (FIN)
AF:
0.0766
AC:
812
AN:
10600
Middle Eastern (MID)
AF:
0.252
AC:
74
AN:
294
European-Non Finnish (NFE)
AF:
0.163
AC:
11096
AN:
67968
Other (OTH)
AF:
0.161
AC:
341
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
959
1917
2876
3834
4793
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
276
552
828
1104
1380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.170
Hom.:
11171
Bravo
AF:
0.148
Asia WGS
AF:
0.256
AC:
894
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.1
DANN
Benign
0.57
PhyloP100
-0.19
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2681472; hg19: chr12-90008959; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.